Renne Abramovich

Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis*

G. Schreiber, R. Abramovich, M. Köster, 2014, The Journal of Biological Chemistry.

Computational redesign of a protein-protein interface for high affinity and binding specificity using modular architecture and naturally occurring template fragments.

V. Sobolev, G. Schreiber, V. Potapov, 2008, Journal of molecular biology.

Binding hot spots in the TEM1-BLIP interface in light of its modular architecture.

D Reichmann, R Abramovich, G Schreiber, 2007, Journal of molecular biology.

An Interferon α2 Mutant Optimized by Phage Display for IFNAR1 Binding Confers Specifically Enhanced Antitumor Activities*

Diego Jaitin, G. Schreiber, R. Abramovich, 2007, Journal of Biological Chemistry.

Binding and activity of all human alpha interferon subtypes.

S. Pestka, G. Schreiber, T. Lavoie, 2011, Cytokine.

Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response

G. Schreiber, H. Hauser, R. Abramovich, 2014, PloS one.